Pitolisant (new indication: narcolepsy with our without cataplexy for patients 6 to 17 years of age)

Subject:

• Active Substance: Pitolisant
• Name: Wakix®
• Therapeutic area: Narcolepsy
• Pharmaceutical company: Bioprojet Deutschland GmbH

Time table:

• Start: 01.04.2023
• Final decision by G-BA: 21.09.2023

Final decision:

• Hint for a non-quantifiable additional benefit